Wall Street spent the day exhaling after a few anxious weeks, though not everyone got the memo. The bond market took a holiday while other corners of finance kept the pace, and a few big names’ headlines refused to quiet down.

Read on, because a few of the stories behind today’s moves are stranger than the headlines make them sound.

The U.S. national debt just passed $40 trillion. Servicing it now costs more than the entire defense budget.

See what that means for your savings.

Inflation is still above 3.5%, so every dollar in cash quietly buys less. Central banks are stockpiling gold at the fastest pace in decades.

Tap for Your Complimentary Gold IRA Guide.

It covers IRA-eligible metals, secure storage, and a BuyBack Guarantee.

Claim Your Complimentary Guide

*This is an advertisement. If you no longer wish to receive promotional emails, please unsubscribe here or write to: 203 Heritage Grove Road, Leander, TX 78641

CoreWeave, the AI trade’s favorite worry, beat revenue estimates and raised its 2026 sales outlook, calming fears that its debt-fueled building spree was racing ahead of demand.

AMD, Broadcom, and Intel each climbed 7% or more in sympathy. Treasury desks were closed for Veterans Day, so the dollar did the talking, hitting a 19-month high as traders bet on a December Fed hike.

At Nvidia, Baird analysts said CEO Jensen Huang may need to step down amid the spy scandal, downgrading the stock and slashing its target 60%.

Brent crude gained about 1.4% as renewed strikes dimmed hopes for a diplomatic fix with Iran. Meanwhile, voters in three states backed bans or slowdowns on data center construction in the midterms, a wrinkle for the AI buildout.

Alphabet is reportedly seeking about $3 billion through its first Hong Kong- and Singapore-dollar bond sales, appointing HSBC and JPMorgan to coordinate as it expands spending on AI infrastructure.

Comstock Resources received a positive credit outlook from Moody’s following its $1.65 billion asset-sale agreement, with proceeds earmarked for debt repayment and a plan to nearly halve financial leverage.

Meta is preparing to hand infrastructure leadership to former AWS executive Dave Brown, with Santosh Janardhan stepping down in early 2027 as the company expands its AI computing operations.

Google is reportedly testing Hydrogen, a faster model in its Gemini 4 lineup, giving employees access through its development platform as it develops an alternative resembling its lower-cost Flash models.

Talen Energy secured a 7-year agreement to sell 750 MW of capacity, locking in approximately $100 million annually from its Ohio power station starting in the 2029/2030 delivery year.

Eos Energy’s zinc-based batteries will supply 100 MWh of storage for West Virginia’s Mammoth Solar campus, with FlexGen selected to integrate the project alongside solar generation and a separate lithium-ion battery system.

Wall Street is bracing for the biggest wave of AI IPOs yet, with OpenAI and Anthropic among the names investors are watching.

Get me the power stock.

Money like that does not stay in software. Whatever AI needs in order to run gets a share, and electricity heads that list.

Send me the ticker by text.

One American energy company is already serving that demand. The window closes when the spotlight lands.

Show me the name now.

*This ad is sent on behalf of Guardian Financial Publishing LLC, doing business as Stable Financial Publishing, 1013 Centre Road Suite 403-D, Wilmington, DE 19805. Nothing here is investment, financial, legal, or tax advice, and it is not a recommendation or solicitation to buy or sell any security. Investing involves substantial risk, including loss of principal; past performance does not guarantee future results. Data-center electricity figures are third-party estimates and projections, and AI IPO timing reflects investor expectations, not company guidance. References to OpenAI, Anthropic and Lawrence Berkeley National Laboratory are for informational purposes only; Stable Financial Publishing is not affiliated with, endorsed by, or sponsored by OpenAI, Anthropic or Lawrence Berkeley National Laboratory. Stable Financial Publishing, its owners, employees and contributors may hold positions in securities mentioned and may trade them at any time. Privacy: https://guardian.pub/privacy-policy/ · Terms: https://guardian.pub/terms-of-service/

Moderna reported observational data linking mNEXSPIKE to a 35.9% lower risk of COVID requiring medical care than Pfizer-BioNTech's Comirnaty vaccine among 294,499 U.S. veterans aged 65 and older.

Eli Lilly reported that 43.7% of patients taking Taltz with Zepbound achieved substantial arthritis relief, versus 15.7% taking Taltz alone, in a 1-year trial involving adults with psoriatic arthritis and excess weight.

AeroVironment secured a $405 million Middle East order for its LOCUST X3 laser weapons, expanding defenses against small and medium drones while planning a regional depot for maintenance, training, and technical support.

Kratos completed a technical review for a U.S. Space Force missile-warning program, advancing ground-system engineering and integration planning as it develops infrastructure connecting satellites with the systems used to track missile threats.

Fossil Group [FOSL] $9.97 (+26.68%)

Fossil just proved a watch company can still tell time. Gross margin jumped nearly 11 points to 59.8%, and adjusted operating income flipped to a $30.2 million profit from a $14.4 million loss a year ago, even with sales basically flat.

Management raised its full-year outlook, and traders gave the old brand a sprint to match.

Capricor Therapeutics [CAPR] $11.22 (+26.49%)

Capricor gave investors a quarterly update after Tuesday’s close, and the stock treated it like a green light with a deadline attached.

The FDA’s decision date for its Duchenne cell therapy, deramiocel, is November 22, after agency reviewers pushed back on trial results at a July advisory meeting. Traders are betting the verdict goes Capricor’s way.

Carlsmed [CARL] $18.60 (+26.44%)

Carlsmed’s third-quarter revenue jumped 65% to $21.6 million, and it raised full-year guidance to $78 million to $80 million.

Its surgeon user base grew more than 60%, and a Medicare payment rule that took effect in October boosted reimbursement for its inpatient lumbar procedures.

Personalized spinal implants are having a moment, and the stock gladly went along.

GIBO Holdings [GIBO] $105.00 (-30.22%)

GIBO Holdings dropped by almost a third, and the chart is doing the explaining. Shares closed near $150 yesterday after a 22% slide, then added another leg lower today on only about 13,000 shares changing hands.

Light trading lets a few sellers move a very pricey share, and the stock has now shed more than 45% in two sessions.

Black Rock Coffee Bar [BRCB] $8.76 (-17.12%)

Black Rock Coffee Bar grew revenue nearly 30% to $66.8 million and opened 11 shops, yet the quarter tasted a little weak. Revenue landed below estimates, and same-store sales growth cooled to 5.8% from 10.8% a year ago.

The company reaffirmed guidance and raised its 2026 opening target to 40, but shares still dropped by about a sixth.

Better Home & Finance [BETR] $15.40 (-16.83%)

Better’s quarter arrived with a warning label. Revenue of $45.1 million missed guidance, and the net loss ran about $33 million, with roughly $8 million of proxy fight expenses widening the adjusted loss.

Management blames interest rates and the boardroom brawl. A planned UK bank sale could bring in about $65 million, but that is a 2027 story.

Around $5 a share, one small company. Wall Street, for the most part, is still missing the link.

Name the company for me.

Humanoid robots, electric cars by the millions, thousands of satellites, reusable boosters — all depend on a handful of metals America is short of.

Send me the free report.

Elon Musk can build the rockets. The metal he cannot dig up, and it funnels through one narrow point.

Text the ticker to me.

*This ad is sent on behalf of Guardian Financial Publishing LLC, doing business as Stable Financial Publishing, 1013 Centre Road Suite 403-D, Wilmington, DE 19805. Nothing here is investment, financial, legal, or tax advice, and it is not a recommendation or solicitation to buy or sell any security. Investing involves substantial risk, including loss of principal; small-cap and low-priced stocks carry particular risk, including the possible loss of your entire investment. Past performance does not guarantee future results. Stable Financial Publishing, its owners, employees and contributors may hold positions in securities mentioned and may trade them at any time. References to Elon Musk and SpaceX are for informational purposes only; Stable Financial Publishing is not affiliated with, endorsed by, or sponsored by Elon Musk or SpaceX. Privacy: https://guardian.pub/privacy-policy/ · Terms: https://guardian.pub/terms-of-service/

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.